Marathon Capital Management’s Marchex MCHX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$103K Buy
64,000
+2,500
+4% +$4.02K 0.02% 174
2026
Q1
$95.3K Hold
61,500
0.02% 160
2025
Q4
$102K Hold
61,500
0.02% 163
2025
Q3
$110K Buy
61,500
+7,500
+14% +$14.9K 0.03% 156
2025
Q2
$117K Buy
54,000
+12,500
+30% +$20.6K 0.03% 157
2025
Q1
$67.6K Buy
41,500
+2,500
+6% +$4.86K 0.02% 152
2024
Q4
$68.3K Buy
39,000
+24,000
+160% +$44.3K 0.02% 150
2024
Q3
$28.1K Hold
15,000
0.01% 151
2024
Q2
$23.1K Hold
15,000
0.01% 140
2024
Q1
$20.6K Buy
+15,000
New +$20.2K ﹤0.01% 151

Other funds holding MCHX

Marathon Capital Management's MCHX Position: Q2 2026 in Review

Marathon Capital Management increased its Marchex (MCHX) stake by 4.1% in Q2 2026, buying an estimated $4.02K and bringing the position to 64,000 shares worth $103K. The position accounts for 0.02% of the portfolio, ranked #174.

Marathon Capital Management first reported a position in MCHX in Q1 2024 and has held it in 10 quarters since. The position peaked at $117K in Q2 2025. 23 funds tracked by Wall St. Rank hold MCHX as of Q2 2026.

  • Marathon Capital Management held 64,000 shares of Marchex worth $103K as of Q2 2026.
  • Marathon Capital Management bought 2,500 Marchex shares in Q2 2026, an estimated $4.02K.
  • Marchex made up 0.02% of Marathon Capital Management's portfolio in Q2 2026, its #174 holding.
  • Marathon Capital Management first reported a position in Marchex in Q1 2024 and has held it in 10 quarters since.
  • Marathon Capital Management's Marchex position peaked at $117K in Q2 2025.
  • 23 funds tracked by Wall St. Rank held Marchex as of Q2 2026.

Based on Marathon Capital Management's 13F filing for Q2 2026, filed 22 Jul 2026.